FOXS1 is increased in liver fibrosis and regulates TGFβ responsiveness and proliferation pathways in human hepatic stellate cells
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2024.105691 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Evelyn A Bates und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, Kentucky, USA. Hauptthemen laut MEDLINE: Forkhead Transcription Factors, Hepatic Stellate Cells, Liver Cirrhosis, Transforming Growth Factor beta. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Liver fibrosis commences with liver injury stimulating transforming growth factor beta (TGFβ) activation of hepatic stellate cells (HSCs), causing scarring and irreversible damage. TGFβ induces expression of the transcription factor Forkhead box S1 (FOXS1) in hepatocytes and may have a role in the pathogenesis of hepatocellular carcinoma (HCC). To date, no studies have determined how it affects HSCs. We analyzed human livers with cirrhosis, HCC, and a murine fibrosis model and found that FOXS1 expression is significantly higher in fibrotic livers but not in HCC. Next, we treated human LX2 HSC cells with TGFβ to activate fibrotic pathways, and FOXS1 mRNA was significantly increased. To study TGFβ-FOXS1 signaling, we developed human LX2 FOXS1 CRISPR KO and scrambled control HSCs. To determine differentially expressed gene transcripts controlled by TGFβ-FOXS1, we performed RNA-seq in the FOXS1 KO and control cells and over 400 gene responses were attenuated in the FOXS1 KO HSCs with TGFβ-activation. To validate the RNA-seq findings, we used our state-of-the-art PamGene PamStation kinase activity technology that measures hundreds of signaling pathways nonselectively in real time. Using our RNA-seq data, kinase activity data, and descriptive measurements, we found that FOXS1 controls pathways mediating TGFβ responsiveness, protein translation, and proliferation. Our study is the first to identify that FOXS1 may serve as a biomarker for liver fibrosis and HSC activation, which may help with early detection of hepatic fibrosis or treatment options for end-stage liver disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, Kentucky, USA.
- Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
- Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
- Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, University of Kentucky College of Medicine, Lexington, Kentucky, USA.
- Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, University of Kentucky College of Medicine, Lexington, Kentucky, USA; Saha Cardiovascular Research Center, University of Kentucky Col…
- Division of Research, Department of Surgery, University of Kentucky College of Medicine, Lexington, Kentucky, USA.
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
- NIAAA NIH HHS
- NIDA NIH HHS
- NCI NIH HHS
- National Institute on Drug Abuse
- National Heart Lung and Blood Institute Division of Intramural Research
Zitieren
APA
Bates, E. A., Kipp, Z. A., Lee, W. H., Martinez, G. J., Weaver, L., Becker, K. N., Pauss, S. N., Creeden, J. F., Anspach, G. B., Helsley, R. N., Xu, M., Bruno, M. E. C., Starr, M. E., & Hinds, T. D. (2024). FOXS1 is increased in liver fibrosis and regulates TGFβ responsiveness and proliferation pathways in human hepatic stellate cells. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.105691
Vancouver
Bates EA, Kipp ZA, Lee WH, Martinez GJ, Weaver L, Becker KN, et al. FOXS1 is increased in liver fibrosis and regulates TGFβ responsiveness and proliferation pathways in human hepatic stellate cells. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.105691
BibTeX
@article{Bates2024,
author = {Bates, Evelyn A and Kipp, Zachary A and Lee, Wang-Hsin and Martinez, Genesee J and Weaver, Lauren and Becker, Kathryn N and Pauss, Sally N and Creeden, Justin F and Anspach, Garrett B and Helsley, Robert N and Xu, Mei and Bruno, Maria E C and Starr, Marlene E and Hinds, Terry D},
title = {FOXS1 is increased in liver fibrosis and regulates TGFβ responsiveness and proliferation pathways in human hepatic stellate cells},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2024.105691}
}
EUVIMED